Skip to main content

Affymetrix, Baylor, OGT, BioSolution, Integromics

Premium
Affymetrix Licenses Array IP to Baylor for CLIA-based CGH Services
 
Baylor College of Medicine has licensed a number of patents from Affymetrix to perform certain microarray services in Clinical Laboratory Improvement Amendments environments, the groups said this week.
 
Under the terms of the deal, scientists at Baylor’s Department of Molecular and Human Genetics will have non-exclusive rights to use Affy’s patents for comparative genomics hybridization microarray services.
 
Arthur Beaudet, chair of Baylor’s DMHG, said the scientists will use the technology “to identify specific genetic abnormalities in many children that have developmental disabilities with previously unknown causes.”
 
The DMHG conducts research in a wide variety of fields, including functional genomics, sequencing, human and mammal genome studies, and numerous diseases.
 
Financial details or the duration of the agreement were not disclosed.
 

 
OGT to Provide Arrays for CHAVI-Funded HIV Vaccine Research Project
 
Oxford Gene Technology has been selected to design and manufacture microarrays for the Innate Discovery Team, a project funded through the Center for HIV-AIDS Vaccine Immunology that is developing vaccines for HIV.

Specifically, OGT will design and develop an optimized oligonucleotide microarray to study genes involved in the cellular immune response in early stage HIV-infected patients. The microarrays will be printed using the OGT inkjet in situ synthesis platform. OGT said that the study will also use its Multi Sample Array format to enable the parallel analysis of multiple samples.

 
Financial details were not discussed.           

 
BioSolution to Market Integromics' Microarray Software in France
 
Spanish software developer Integromics said last week that BioSolution, a Paris-based biotech consulting company, will market its products in France.
 
Integromics’ software focuses on microarray management, including data analysis and data mining.
 
Financial terms of the deal were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.